Senior or Principal Veterinary Pathologist

Req ID #:  63513
Location: 

Laval, Quebec, CA, H7V 4B3

For 70 years, Charles River employees have worked together to assist in the discovery, development and safe manufacture of new drug therapies. When you join our family, you will have a significant impact on the health and well-being of people across the globe. Whether your background is in life sciences, finance, IT, sales or another area, your skills will play an important role in the work we perform. In return, we’ll help you build a career that you can feel passionate about.

Job Summary

 

We are seeking an experienced Senior or Principal Veterinary Pathologist for the group of Pathology, located in Laval (greater Montreal area) in Canada.

 

The new Veterinary Pathologist will provide scientific expertise in pathology according to sponsors’ requirements and scientific and technical expertise in immunohistochemistry techniques and associated molecular pathology application.  Additionally, this role will supervise necropsies and perform histopathological examinations on a wide variety of laboratory species. Writing pathology reports in support of the toxicology program will also be part of the responsibilities, as will conducting peer reviews in pathology and reviewing clinical pathology data. Management and mentoring of new pathologists is expected. 

 

 

About the group of Pathology

The team, which reports to a Senior Director of Pathology, is composed of 7 pathologists, 6 of whom are currently board-certified, with a diversity of backgrounds, strengths and origins. Our common mission is to deliver superior quality pathology services to our customers and teamwork is an important and integral part of our daily work life.

 

Job Requirements

 

  • Doctorate in Veterinary Medicine or equivalent, and formal Residency training in Veterinary Pathology;
  • Board certification by the American College of Veterinary Pathologists (ACVP) or European College of Veterinary Pathologists (ECVP);
  • 5 to 10 years of relevant experience in toxicologic or investigative pathology in a CRO, pharmaceutical or biotechnology industry;
  • Fluent in spoken and written English required, French would be an asset;
  • Management skills and mentoring experiences;
  • Strong knowledge of related legislation, principles, practices and procedures;
  • High degree of self-motivation with effective organizational and time management skills;
  • Collaborative and team building skills.

About Safety Assessment
Charles River is committed to helping our partners expedite their preclinical drug development with exceptional safety assessment services, state-of-the-art facilities and expert regulatory guidance. From individual specialty toxicology and IND enabling studies to tailored packages and total laboratory support, our deeply experienced team can design and execute programs that anticipate challenges and avoid roadblocks for a smooth, efficient journey to market.  Each year approximately 120 investigational new drug (IND) programs are conducted in our Safety Assessment facilities.

 

About Charles River
Charles River is an early-stage contract research organization (CRO). We have built upon our foundation of laboratory animal medicine and science to develop a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP, to support clients from target identification through preclinical development. Charles River also provides a suite of products and services to support our clients’ clinical laboratory testing needs and manufacturing activities. Utilizing this broad portfolio of products and services enables our clients to create a more flexible drug development model, which reduces their costs, enhances their productivity and effectiveness to increase speed to market.

 

With over 17,000 employees within 90 facilities in 20 countries around the globe, we are strategically positioned to coordinate worldwide resources and apply multidisciplinary perspectives in resolving our client’s unique challenges. Our client base includes global pharmaceutical companies, biotechnology companies, government agencies and hospitals and academic institutions around the world. And in 2019, revenue increased to $2.62 billion.

 

At Charles River, we are passionate about our role in improving the quality of people’s lives. Our mission, our excellent science and our strong sense of purpose guide us in all that we do, and we approach each day with the knowledge that our work helps to improve the health and well-being of many across the globe. We have proudly supported the development of ~85% of the drugs approved by the FDA in 2019.